Lutathera (LU-177 dotatate radiopharmaceutical)

Ended Awarded Last action

Contract number
36C25722N0204
Awardee
Awarding agency
Obligated
-$56,302

Award facts

Contract value 0% obligated
$925,206.54 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · Lutathera (LU-177 dotatate radiopharmaceutical) DE-OB -$118,141
Other Administrative Action P00003 -$431,864
Other Administrative Action P00002 -$480,137
Supplemental Agreement for work within scope P00001 $973,839
Original award $0

About this award

This federal contract award was made by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the radiopharmaceutical drug LUTATHERA (lutetium Lu 177 dotatate) and has a ceiling value of $925,206.54. It is a delivery order contract issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which is a Governmentwide Acquisition Contract (GWAC) managed by the VA. The contract does not have a small business set-aside designation. Advanced Accelerator Applications USA Inc. is the prime contractor and has no major subcontractors listed. This contract supports the VA's provision of specialized cancer treatment and diagnostic imaging services to veterans through the supply of critical radiopharmaceutical products.

Quick answers

Who was awarded contract 36C25722N0204?

36C25722N0204 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on January 28, 2022.

How much is contract 36C25722N0204 worth?

The government has obligated -$56,302 on 36C25722N0204. Its current value, with exercised options, is $925,207.

Is contract 36C25722N0204 an order under another contract?

Yes. 36C25722N0204 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25722N0204 competed?

The extent of competition for 36C25722N0204 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award